Protein Lysine Acetylated/Deacetylated Enzymes and the Metabolism-Related Diseases
Protein Lysine Acetylated/Deacetylated Enzymes and the Metabolism-Related Diseases作者机构:Liaocheng University School of Life Sciences Liaocheng China Liaocheng University School of Pharmacy Liaocheng China
出 版 物:《Advances in Bioscience and Biotechnology》 (生命科学与技术进展(英文))
年 卷 期:2016年第7卷第11期
页 面:454-467页
学科分类:081704[工学-应用化学] 07[理学] 08[工学] 0817[工学-化学工程与技术] 070303[理学-有机化学] 0703[理学-化学]
主 题:Lysine Acetylation Acetyl CoA Metabolism-Related Disease Cardiovascular Disease Obesity
摘 要:Lysine acetylation is a reversible posttranslational modifcation, an epigenetic phenomenon, referred to as transfer of an acetyl group from acetyl CoA to lysine ε- amino group of targeted protein, which is modulated by acetyltransferases (histone/ lysine (K) acetyltransferases, HATs/KATs) and deacetylases (histone/lysine (K) deacetylases, HDACs/KDACs). Lysine acetylation regulates various metabolic processes, such as fatty acid oxidation, Krebs cycle, oxidative phosphorylation, angiogenesis and so on. Thus disorders of lysine acetylation may be correlated with obesity, diabetes and cardiovascular disease, which are termed as the metabolic complication. With accumulating studies on proteomic acetylation, lysine acetylation also involves in cell immune status and degenerative diseases, for example, Alzheimer’s disease and Huntington’s disease. This review primarily summarizes the current studies of lysine acetylation in metabolism modulation and in metabolism-related diseases, such as cardiovascular disease and fat metabolism disorder.